About PCAS

Company Description

With close to 7% of its net sales earmarked for R&D and a large international footprint, PCAS is the preferred industrial partner for market-leading major global groups. The company offers a growing range of proprietary products and solutions in leading-edge segments and also includes very high-potential subsidiary: Protéus in biotechnology. Boasting especially high standards, PCAS generated net sales of €2194,1 million in 2020 and employs more than 1071 people in six countries.

Year founded

1962

Served area

Worldwide

Headcount

1,071

Headquarters

21 Chemin de la Sauvegarde, 69134 Ecully Cedex – France

Shareholder information

Shares outstanding

15,141,725

IPO

Oct. 1, 2014

Stock exchange(s)

Euronext Paris

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.